Tianlong Strengthens Transfusion Safety with Innovative Blood Screening Solutions on World AIDS Day 2025

XI'AN, China, Nov. 28, 2025 /PRNewswire/ -- On World AIDS Day 2025, Tianlong reiterates its commitment to advancing global transfusion safety by presenting its fully integrated nucleic acid blood screening solution. Combining high automation with high-sensitivity NAT reagents, the solution enables earlier detection of low-viral-load infections—an essential step in reducing transfusion-transmitted HIV and safeguarding patients who rely on safe blood.

Strengthening Blood Safety Through Earlier Detection

Ensuring blood safety remains one of the most effective defenses against transfusion-transmitted infections. By enhancing screening accuracy and enabling laboratories to detect HBV, HCV, HIV-1, and HIV-2 during early infection stages, Tianlong supports global public health efforts and reinforces trust in every unit of donated blood.

A Fully Automated Workflow for Blood Screening Application

At the core of Tianlong's solution is the Aurora PANA X6 Fully Automated Nucleic Acid Extraction System, developed for blood centers and large-scale screening programs.

When paired with the Gentier 96 Real-time PCR System, the platform enables a true sample-in, result-out process, integrating: original tube loading, barcode identification, automated capping/decapping, direct sample pooling, nucleic acid extraction, PCR setup, PCR amplification. This end-to-end automation reduces manual steps, lowers contamination risk, and enhances operational safety.

High Throughput for High-Volume Blood Screening Demands

Aurora PANA X6 processes up to 576 samples per run and 1,152 samples per day, providing the capacity required for high-volume screening. The ability to load original sample tubes with automated capping/decapping ensures consistent, contamination-controlled operations.

Direct Pooling and Flexible Screening Modes

The system conducts direct pooling into deep-well plates—eliminating the need for extra collection tubes—and supports individual testing and 6-in-1 pooled testing, allowing laboratories to balance efficiency and sensitivity.

To ensure reliable performance, the platform features independent work zones, HEPA filtration, UV disinfection, controlled airflow, and anti-drip design, delivering robust biosafety in demanding laboratory environments.

High-Sensitivity NAT Reagents to Detect Low-Load Infections

KHB's high-sensitivity NAT reagent complements Tianlong's automated platform, using qualitative real-time PCR in an all-in-one format that integrates extraction and amplification.

The reagent system is engineered to detect HBV, HCV, HIV-1, and HIV-2 even at low viral loads, enabling laboratories to identify window-period infections, reduce the risk of transfusion-transmitted diseases and improve overall blood supply safety.

On World AIDS Day, this early-window detection capability highlights a shared commitment to protecting every life connected to blood donation and transfusion.

Committed to Safer Transfusions — Today and Every Day

"On World AIDS Day, we are reminded that every safe transfusion represents a promise of protection for another human life," said Li Ming, CEO of Tianlong. "Our mission is to equip laboratories with solutions that enhance accuracy, strengthen biosafety, and support the global effort to prevent HIV transmission."

About Tianlong

Tianlong Science and Technology, founded in 1997, is a pioneer in the field of genetic testing and molecular diagnostics. Together with our group company Shanghai Kehua Bio-engineering Co., Ltd. (KHB), we have established five core technology platforms — immunodiagnostics, biochemistry, molecular diagnostics, POCT, and mass spectrometry, specializing in the research, development, and manufacturing of instruments and in vitro diagnostic (IVD) reagents — offering comprehensive solutions across a wide range of sectors, including clinical diagnostics, blood centers, disease control, veterinary epidemic prevention, and food safety.

For more information, please visit Tianlong's official website and its LinkedIn, Facebook, and Twitter pages.

https://www.medtl.net/

linkedin.com/company/tianlongbiotech/ 

https://www.facebook.com/TianlongGlobal/

https://x.com/TianlongGlobal 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Tianlong Strengthens Transfusion Safety with Innovative Blood Screening Solutions on World AIDS Day 2025

TOKYO, April 2, 2026 /PRNewswire/ -- GA technologies Co., Ltd. (Headquarters: Minato-ku, Tokyo; President, CEO: Ryo Higuchi; Stock Code: 3491; hereinafter referred to as the "Company") announces that its AI real estate investment service, "RENOSY," has launched an initiative to rebrand "Renters Warehouse" (operated by RW OpCo, LLC [Headquarters: United States], a Group company), as "RENOSY by Renters Warehouse."

URL: https://www.renterswarehouse.com/

• Background and Outlook of the Brand Integration and Renewal

Since its founding in 2013, the Company has operated under its corporate philosophy:

"Spark excitement and inspiration by fusing technology with innovation to propel the world forward." The Company's core business is the AI real estate investment service "RENOSY," which leverages technology to provide unique one-stop services for property purchase, management, and sale.

RW OpCo, LLC, founded in 2007, operates the real estate investment marketplace "Renters Warehouse." Primarily serving individuals and institutional investors in the United States, the platform functions as an online marketplace and currently operates in 18 states and 31 locations across the country.

The Company completed the consolidation of RW OpCo, LLC as a subsidiary in March 2024 and began providing real estate services in the U.S. market.^[1] Since the fiscal year ending October 2025, the business has maintained strong performance, achieving quarterly profitability and growing rapidly to become the Company's third pillar of profit.^[2]

The Company has now moved to rebrand its U.S. business from "Renters Warehouse" to "RENOSY by Renters Warehouse," aiming to drive further growth in the U.S. market and maximize group synergies. Through the full-scale expansion of "RENOSY" in the U.S. market, the Company looks to promote the adoption of services that enable reliable, seamless, and optimal asset formation through real estate in the country.

The impact of this matter on the Company's business results is insignificant.

• AI Real Estate Investment RENOSY

RENOSY is an AI real estate investment service that utilizes technology. Reliable, seamless, and optimal asset-building through real estate is realized by providing one-stop support for the purchase, management, and sale of property, maximizing operational effectiveness. An extensive product lineup is offered that includes condominiums, apartments, and detached houses, etc. Surveys conducted by Tokyo Shoko Research have ranked RENOSY No. 1 in Japan in real estate investment sales and purchases.^[3]

1. Press release released by GA technologies Co., Ltd. "Notice Regarding Completion of Ownership Acquisition of RW OpCo, LLC, a U.S. Company" (releasing date: March 1, 2024) https://ssl4.eir-parts.net/doc/3491/tdnet/2405406/00.pdf

2. Presentation material released by GA technologies Co., Ltd. "FY2025. 10 Full-year Financial Results" (releasing date: December 15, 2025) https://ssl4.eir-parts.net/doc/3491/tdnet/2731394/00.pdf, and "FY2026. 10 1Q Financial Results" (releasing date: March 17, 2026) https://ssl4.eir-parts.net/doc/3491/tdnet/2777310/00.pdf

3. Press release released by GA technologies Co., Ltd. "AI Real Estate Investment Service RENOSY is Ranked No. 1 in Japan in Sales of Investment Condominiums and Apartments for the Second Consecutive Year" (releasing date: March 31, 2026) https://www.ga-tech.co.jp/news/wherjxrzxv88n_r/